Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

Navidea Biopharmaceuticals Inc

+ Add to Watchlist

NAVB:US

1.6900 USD 0.0400 2.31%

As of 14:08:03 ET on 01/28/2015.

Snapshot for Navidea Biopharmaceuticals Inc (NAVB)

Open: 1.7500 Day's Range: 1.6800 - 1.7700 Volume: 268,361
Previous Close: 1.7300 52wk Range: 0.9674 - 2.1200 1-Yr Rtn: -4.52%

Stock Chart for NAVB

No chart data available.
  • NAVB:US 1.6900
  • 1D
  • 1M
  • 1Y
1.7300
Interactive NAVB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NAVB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2869
Est. EPS (USD) (12/2014) -0.2500
Est. PEG Ratio -
Market Cap (M USD) 254.75
Shares Outstanding (M) 150.74
30 Day Average Volume 1,169,595
Price/Book (mrq) -
Price/Sale (ttm) 53.9321
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NAVB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NAVB

Navidea Biopharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer.

Thomas H Tulip "Thom"President/Chief Business OfcrRick GonzalezChief Executive Officer
Brent L LarsonExec VP/CFO/Treasurer/SecyThomas J KlimaSenior VP/Chief Commercial Ofcr
More Company Profile & Key Executives for NAVB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil